computer science meet medicine
Computer Science Meets Medicine in Drug Discovery
AI has the potential to revolutionize healthcare worldwide. In drug discovery, AI has already shown success. Sumitomo Dainippon Pharma and the UK-based AI company Exscientia developed DSP-1181 to treat obsessive compulsive disorder. In clinical trials for treatment of solid tumors, the clinical-stage, AI-powered biotech BERG's BPM31510 (ubidecarenone) has already been granted Orphan Drug Designation by the FDA to treat pancreatic cancer and epidermolysis bullosa, a rare skin disorder causing blistering. AI-led drug discovery for COVID-19 is also in the works.